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Clinical and Laboratory Data of AffeCTed Family
Members
IIC, mother of the propositus, is the probable carrier of
the Von Willebrand gene. She was clinically unaffected,
and the factor VIII level was 80 0 6 on 2 separate oc-
casions, but the bleeding time was prolonged to 8t min.
I1ili and lIU, female cousins of the propositus, were
both clinically unaffected. Coagulation studies showed
normal factor VIII levels (75 0 0 and 95 0 0 respectively). but
the bleeding times of both were prolonged Of and 8 min.
respectively).
IlIB, the propositus, a Bantu female aged 21 years, was
admitted to hospital 4 days postpartum because of per-
sistent vaginal bleeding. Clinical examination was other-
wise normal. Therapy consisted of antibiotics, blood
transfusions and curettage, following which the vaginal
bleeding diminished. Five days
later vaginal bleeding again be-
came severe, and continued despite
a further 3 curettages and
numerous blood transfusions (Fig.
2). A bleeding diathesis was sus-
pected and coagulation studies
showed a factor VIII level of 80 0
with a bleeding time of 18t min.
(Table I). A provisional diagnosis
of Von Willebrand's disease was
made. Further therapy consisted of
transfusions of whole blood, fresh
frozen plasma, vitamin K and
calcium. This therapy failed to con-
trol the haemorrhage adequately
(Fig. 2). Four units of 'fibrinogen
concentrate' were then administered
daily for 3 consecutive days. Before
use, each unit was reconstituted to
affected members (1118, I1IC, IlIG, IVA). The propositus
1I18, her son IVA and her half-brother lIIG will be di -
cussed in detail. I1IC, the brother of the propositus. died
at the age of I year following uncontrollable haemorrhage
from a lacerated lip. Coagulation studies were not carried
out on this infant, but it is reasonable to conclude that he
too was severely affected.
The trait appears to have been tran mitted through
the mother (JIC) of the propositus (I1IB). The pedigree i
complicated by the mother's (1IC) second marriage to the
brother (JID) of her first spouse (JIB). Her first spouse
(lIB) died of cardiac failure, and her second spouse (110)
was found to be normal, both on clinical examination and
coagulation studies. Four siblings of the husbands (lIB.
lID) had no history of clinical bleeding. Two maternal
cousins (I1IH, IIIJ) of the propositus were affected. The
most probable mode of transmission of the Von Wille-
brand trait is through the family of the mother of the
propositus.
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Von Willebrand's disease, an autosomal-dominant in-
herited bleeding disorder, is characterized by a prolonged
bleeding time and a low antihaemophilic factor (factor
VIII) level. The disease was first described in 1926 by
Von Willebrand when investigating a bleeding diathesis
among the Aaland Islanders.' Although well described in
White populations, the disease appears to be a rarity
among the Asiatic and Negro races.'·3 We have been un-
able to find documented cases of Von Willebrand's di-
sease in the Bantu.
This paper presents the first report of Von Willebrand's
disease in the South African Bantu. The family is of the
Tswana ethnic group. Three members presented with
severe clinical bleeding and a fourth died of haemorrhage
in infancy.
MATERIALS A D METHODS
Platelet count, bleeding time (Ivy), prothrombin time and
factor VIII assay were carried out by standard pro-
cedures: Kaolin partial thromboplastin time was
measured by the method of Langdell et al.; plasma fi-
brinogen by the method of Ellis and Stransky: and
euglobulin lysis time by the method of Nilsson and
Olow.' Platelet adhesiveness in vivo was measured by the
method of Borchgrewinck,' and in viTro by the method of
Hellem." ADP-induced clumping and platelet factor 3
availability (platelet thromboplastic activity) were assayed
by the method of Hardisty and Ingram.'o
'Fibrinogen concentrate' ('human fibrinogen dried'-
South African Blood Transfusion Service) corresponded to
Cohn's fraction I. It was prepared by the ethanol extrac-
tion method from time-expired plasma," and the factor
VIII content, although variable. was consistently low.
Family STudies (Fig. I)
Four generations in the family tree show 4 severely
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TABLE I. LABORATORY DATA 0 THREE SEVERELY AFFECTED CASES OF VON WlLLEBRA 'D'S DISEASE
Partial Platelet studies EUJllo-
Bleed- thrombo- Factor Pro- bufin
ing plastill VJIf Platelet ADP Stickiness Stickiness Factor 3 thrombill Fibrino- lysis
time time level cOllnt/ aggre- in vivo in vitro availability time gen time
Case (min.) (sec.) (%) CII. mm. gation (%) (%) (%) (sec.) (mg./100 ml.) (hours)
I1IB 15 65 8 235,000 ormal 84 68 40 11 ·3 237 3
IIIG 9; 6 350,000 ormal 10· I
Adequate
(VB 73 2 on film 11·0
ormal 140,000-
range 2-7 35-45 50-150 400,000 Normal 65 50 25-75 10-12 210 3-5
for hyperbilirubinaemia, possibly due to absorption of
blood from an occipital cephalhaematoma sustained at
5 10 15 20 25
HOURS POST - INFUSION
Fig. 3. Factor VIII levels in the propositus (I1IB) follow-
ing infusion of 1,000 m\. fresh frozen plasma (e e)
and 200 ml. 'fibrinogen concentrate' (0 - - - - - 0). The factor
VIII concentration of the fresh frozen plasma was 45 ~o
and of the 'fibrinogen concentrate' less than I ~~.
a concentration of I G of resuspended fractionated pro-
tein per lOO ml. Factor VIII in the 'fibrinogen concen-
trate· ranged from under I ~o to 120 0 and the fibrinogen
concentration was I G /100 m!. Following this therapy
the bleeding ceased completely. On the ninth day after
cessation of therapy with the 'fibrinogen concentrate', the
patient passed a large intra-uterine clot per vaginam and
heavy vaginal bleeding recurred. This episode of vaginal
bleeding was again controlled by the 'fibrinogen concen-
trate· (Fig. 2).
On careful questioning, the patient admitted to severe
menorrhagia for many years. A tooth extraction some
years previously had been followed by severe haemor-
rhage, necessitating blood transfusion.
Further coagulation studies were subsequently carried
out (Table I). Platelet number, morphology and function
were normal. The factor VIII level was less than 10% and
the bleeding time markedly prolonged on numerous oc-
casions. The final confirmation of Von Willebrand's di-
sea e was made with infusion studies. The factor VIII
level rose rapidly after infusions of both fresh frozen
plasma and the 'fibrinogen concentrate' and subsequently
fell slowly (Fig. 3). The factor VIII concentration of the
fresh frozen plasma was 45% and of the 'fibrinogen con-
centrate', infused in this study, under 1%.
IVA, the infant son of the propositus, was admitted to
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Fig. 2. Clinical course of the propositus (IlIB). D & C = Dilatation
and curettage.
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birth. Continual oozing from the umbilical stump after the
exchange transfusion and excessive bleeding from vene-
puncture and intramuscular injection sites suggested a
haemorrhagic diathesis. Laboratory investigations revealed
a factor VIll level of 2°~ (Table I).
ruG, a male aged 3 years, had been investigated in
1965, when he presented with numerous subcutaneous
haematomata. The bleeding time (Duke) was prolonged
and the factor VIII level was 6% (Table I). Platelet func-
tion studies were normal. He died early in 1968 of a
probable cerebral haemorrhagic episode.
DISCUSSION
Von Willebrand's disease, a bleeding disorder affecting
both exes, is characterized by a prolonged bleeding time
and reduced factor VIII level. These abnormalities were
demonstrated in the Bantu family presented in this report,
7 members of the family-representing 4 generations-
showing prolonged bleeding times and/ or low factor
VIII levels.
The commonest form of hereditary factor VIII defi-
ciency is classical haemophilia. This disease, with its sex-
linked recessive mode of inheritance, affects males but
almost never females, and the bleeding time is normal.
Differentiation between Von Willebrand's disease and
haemophilia can be made by noting the response in factor
VIII level following infusion of stored plasma. The in-
fusion of plasma deficient in factor VIII fails to raise the
factor VIII level in haemophilia. It is postulated that in
classical haemophilia there is deficiency of the end-pro-
duct of factor VIII synthesis.'" In Von Willebrand's di-
sease, however, infusion of plasma with low factor vm
concentration will result in a rapid and sustained rise in
the factor VIII level, due to 'in vivo complementation'
of factor VIII: This feature is thought to be due to the
replacement of a postulated precursor substance, absent
in Von Willebrand's disease, with subsequent intrinsic
factor VIII synthesis:,13 This was demonstrated by the
propositus, where infusion of 'fibrinogen concentrate', low
in factor VIII, resulted in a rapid rise in factor VIII level,
with a subsequent slow fall-off in activity over 24 hours.
There can be no doubt that the family here described
represents an example of Von Willebrand's disease.
Seme of the affected members of the family with pro-
longed bleeding times had factor VIII levels within the
normal range. These subjects are only mildly affected
with the disease. Factor VIII levels are variable in affected
families, and may even vary from time to time in the
same patient." It is possible that these mildly affected
subjects may demonstrate lower factor VIII levels if re-
peatedly tested."
Abnormalities in platelet function have been described
in Von Willebrand's disease. Platelet adhesiveness and
ADP aggregation were shown to be defective in some
patients.",1. These features were not demonstrated in the
members of the family described, but this is not un-
expected, for many other investigators have been unable
to show platelet function defects in otherwise typical
examples of Von Willebrand's disease:'"
Von Willebrand's disease is transmitted as an auto-
somal-dominant inherited condition: In the present
family, a study of the third and fourth generations shows
the typical pattern of autosomal-dominant inheritance.
An inadequate number of members of the first 2 genera-
tion were available for te ting. The variability of ex-
pressivity of the coagulation defects necessitates repeated
evaluation of the apparently unaffected ubject. H
The therapy of Von Willebrand's disea e differs from
that of cia sical haemophilia. The bleeding diathesi in
both diseases is related directly to the factor VIII level.
In haemophilia correction of the low factor VIII concen-
tration is achieved passively by transfusing blood product
containing high concentrations of factor VIII such a
cryoprecipitate, fresh and fresh frozen plasma and
'haemophilic factor concentrates' prepared by pharma-
ceutical manufacturers. In Von Willebrand's di ea e the
correction may be either active or passive, using fresh or
fresh frozen plasma. Coho's fraction I or 'fibrinogen
concentrate'."" These plasma or plasma derivatives with
a high factor VIII content will result in an immediate
rise in the recipient's factor VIII level, followed in many
instances by 'complementation' and a further increment
in the factor VIII level, and a slow fall over 24 hours.
A 'fibrinogen concentrate' with low factor VIU activity
will cause a slow rise in the factor VIII level to a maxi-
mum about 4 hours after infusion, corresponding to
intrinsic factor VIII synthesis, with a slow faU over the
next 24 hours: The propositus aptly demonstrates these
features when both fresh frozen plasma and a 'fibrinogen
concentrate' were administered. In the control of the
vaginal bleeding in the propositus, a response wa noted
with both fresh frozen plasma and 'fibrinogen concen-
trate'. It appeared that the response to the 'fibrinogen
concentrate' was better, but this may be dose related.
SUMMARY
A bleeding disease in a Bantu family has been investigated. The
disease is transmitted in the family in an autosomal-dominant
pattern. The affected members of the family show low plasma
levels of antihaemophilic globulin (factor VIII) and/or a pro-
longed bleeding time. The low factor VIII level was shown to
rise following infusion of plasma fractions low in factor VIII.
These features are diagnostic of Von Willebrand's disease,
which has to our knowledge not been previOUSly described in
the Bantu.
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